Patient selection, embolization technique, procedural workflow, and clinical outcomes with preablation TAE for large, ...

Discover the latest articles and news in related subjects. Targeted Therapies in Advanced Renal Cell Carcinoma Nephron-sparing surgery for small-to-medium sized renal tumors has undoubtedly become a ...

A six-patient case series from Italy reports complete tumor ablation with no major complications using CT-guided cryoablation ...

"ProSense® received a high level of interest at this prestigious breast cancer conference in Europe where our cryoablation system is gaining increasing commercial traction driven by regulatory ...

A study presented at the Society of Interventional Radiology’s 37th Annual Scientific Meeting in San Francisco, Calif. shows that percutaneous cryoablation may be provide another treatment alternative ...

March 11, 2009 (San Diego, California) — Interventional cryoablation is an effective treatment for small renal tumors, and should be the gold standard or first treatment option for all patients with ...

A minimally invasive procedure that destroys cancer cells by freezing them is as effective as surgery for treating early-stage kidney cancer, offering similar 10-year survival rates with a lower rate ...

Feasibility study of adjuvant vinorelbine and cisplatin in Japanese patients with completely resected stage II-IIIA non-small cell lung cancer. Background: Percutaneous cryoablation for lung tumors ...

Two new studies support an expansion of the role of percutaneous cryoablation in the management of renal masses. The use of ablative techniques was originally restricted to those patients harboring ...

Racial and gender disparities in renal cell carcinoma. The effects of HDIL-2 in combination with pazopanib or sunitinib on PBMCs’ function and RCC cells’ apoptosis: Preliminary in vitro data.

Introduction: The widespread use of ultrasound and cross-sectional imaging has led to a steady increase in the incidental discovery of renal masses. Most of them are treated with partial nephrectomy ...

CAESAREA, Israel, July 29, 2026 /PRNewswire/ -- IceCure Medical Ltd. (Nasdaq: ICCM) ("IceCure," "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that ...